John Brady - Publications

Affiliations: 
National Cancer Institute, Rockville, MD, United States 

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Chevalier SA, Turpin J, Cachat A, Afonso PV, Gessain A, Brady JN, Pise-Masison CA, Mahieux R. Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission. Plos Pathogens. 10: e1003917. PMID 24586148 DOI: 10.1371/journal.ppat.1003917  0.318
2012 Chevalier SA, Durand S, Dasgupta A, Radonovich M, Cimarelli A, Brady JN, Mahieux R, Pise-Masison CA. The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties. Plos One. 7: e41003. PMID 22911729 DOI: 10.1371/journal.pone.0041003  0.331
2009 Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, Ozbun L, Samimi G, Brady J, Randonovich M, Pise-Masison CA, et al. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell. 16: 521-32. PMID 19962670 DOI: 10.1016/J.Ccr.2009.10.018  0.311
2008 Chung HK, Pise-Masison CA, Radonovich MF, Brady J, Lee JK, Cheon SY, Markham P, Cristillo A, Pal R. Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate Viral Immunology. 21: 411-423. PMID 19115930 DOI: 10.1089/Vim.2008.0076  0.346
2008 Chevalier SA, Ko NL, Calattini S, Mallet A, Prévost MC, Kehn K, Brady JN, Kashanchi F, Gessain A, Mahieux R. Construction and characterization of a human T-cell lymphotropic virus type 3 infectious molecular clone. Journal of Virology. 82: 6747-52. PMID 18417569 DOI: 10.1128/Jvi.00247-08  0.31
2007 Cho WK, Zhou M, Jang MK, Huang K, Jeong SJ, Ozato K, Brady JN. Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein. Journal of Virology. 81: 11179-86. PMID 17686863 DOI: 10.1128/Jvi.00408-07  0.312
2007 Bonome T, Samimi G, Randonovich M, Brady J, Ghosh S, Ng S, Mok SC, Birrer MJ. A stromal-associated gene expression signature predicting for survival in a series of patients with advanced high-grade serous ovarian cancer Journal of Clinical Oncology. 25: 5552-5552. DOI: 10.1200/Jco.2007.25.18_Suppl.5552  0.309
2007 Ozbun L, Bonome T, Radonovich M, Pise-Masison C, Brady J, Caplen N, Johnson M, Mok SC, Birrer MJ. Use of predictive gene expression signature from advanced-stage serous papillary ovarian cancer to identify biologically relevant molecular targets for chemoresponse Journal of Clinical Oncology. 25: 5500-5500. DOI: 10.1200/Jco.2007.25.18_Suppl.5500  0.314
2006 Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 690-700. PMID 16467078 DOI: 10.1158/1078-0432.Ccr-05-1110  0.3
2006 Ozbun L, Bonome T, Johnson ME, Radonovich M, Pise-Masison C, Brady J, Mok S, Birrer ME. Gene expression signature predicts chemoresponse of microdissected papillary serous ovarian tumors Journal of Clinical Oncology. 24: 5064-5064. DOI: 10.1200/Jco.2006.24.18_Suppl.5064  0.339
2005 Brady J, Kashanchi F. Tat gets the "green" light on transcription initiation. Retrovirology. 2: 69. PMID 16280076 DOI: 10.1186/1742-4690-2-69  0.436
2005 Kashanchi F, Brady JN. Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene. 24: 5938-51. PMID 16155601 DOI: 10.1038/Sj.Onc.1208973  0.359
2005 Pise-Masison CA, Jeong SJ, Brady JN. Human T cell leukemia virus type 1: the role of Tax in leukemogenesis. Archivum Immunologiae Et Therapiae Experimentalis. 53: 283-96. PMID 16088313  0.328
2005 Ammosova T, Washington K, Debebe Z, Brady J, Nekhai S. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription. Retrovirology. 2: 47. PMID 16048649 DOI: 10.1186/1742-4690-2-47  0.332
2005 Kehn K, Fuente Cde L, Strouss K, Berro R, Jiang H, Brady J, Mahieux R, Pumfery A, Bottazzi ME, Kashanchi F. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene. 24: 525-40. PMID 15580311 DOI: 10.1038/Sj.Onc.1208105  0.397
2005 Pise-Masison CA, Brady JN. Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function. Frontiers in Bioscience : a Journal and Virtual Library. 10: 919-30. PMID 15569630 DOI: 10.2741/1586  0.327
2005 Donninger H, Bonome T, Li J, Park D, Radonovich M, Pise-Masison C, Brady J, Barrett JC, Mok SC, Birrer MJ. Expression profiling of microdissected papillary serous ovarian epithelial cancers identifies genes describing the unique phenotypes of borderline and malignant tumors Journal of Clinical Oncology. 23: 5029-5029. DOI: 10.1200/Jco.2005.23.16_Suppl.5029  0.303
2004 Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH, Barrett JC, Birrer MJ. Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways Oncogene. 23: 8065-8077. PMID 15361855 DOI: 10.1038/Sj.Onc.1207959  0.317
2003 Watanabe T, Sugaya M, Atkins AM, Aquilino EA, Yang A, Borris DL, Brady J, Blauvelt A. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells Journal of Virology. 77: 6188-6196. PMID 12743275 DOI: 10.1128/Jvi.77.11.6188-6196.2003  0.396
2002 Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J, Guillerm C, Gessain A, Brady JN. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Research. 62: 3562-71. PMID 12068005  0.303
2002 Nekhai S, Zhou M, Fernandez A, Lane WS, Lamb NJ, Brady J, Kumar A. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription. The Biochemical Journal. 364: 649-57. PMID 12049628 DOI: 10.1042/Bj20011191  0.393
2002 Bharucha DC, Zhou M, Nekhai S, Brady JN, Shukla RR, Kumar A. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat. Virology. 296: 6-16. PMID 12036313 DOI: 10.1006/Viro.2002.1438  0.339
2001 Chiao C, Bader T, Stenger JE, Baldwin W, Brady J, Barrett JC. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells. Aids Research and Human Retroviruses. 17: 1125-1132. PMID 11522182 DOI: 10.1089/088922201316912736  0.328
1999 Gallia GL, Darbinian N, Tretiakova A, Ansari SA, Rappaport J, Brady J, Wortman MJ, Johnson EM, Khalili K. Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proceedings of the National Academy of Sciences of the United States of America. 96: 11572-7. PMID 10500218 DOI: 10.1073/Pnas.96.20.11572  0.554
1998 Sawaya BE, Thatikunta P, Denisova L, Brady J, Khalili K, Amini S. Regulation of TNFα and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells Journal of Neuroimmunology. 87: 33-42. PMID 9670843 DOI: 10.1016/S0165-5728(98)00044-7  0.57
1997 Méndez E, Kawanishi T, Clemens K, Siomi H, Soldan SS, Calabresi P, Brady J, Jacobson S. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: Induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells Journal of Virology. 71: 9143-9149. PMID 9371571 DOI: 10.1128/Jvi.71.12.9143-9149.1997  0.403
1997 Malik KF, Jaffe H, Brady J, Young WS. The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U. Brain Research. Molecular Brain Research. 45: 99-107. PMID 9105675 DOI: 10.1016/S0169-328X(96)00238-0  0.35
1992 Bosselut R, Lim F, Romond P, Frampton J, Brady J, Ghysdael J. Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression. Virology. 186: 764-769. PMID 1733110 DOI: 10.1016/0042-6822(92)90044-P  0.448
1988 Jeang KT, Boros I, Brady J, Radonovich M, Khoury G. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. Journal of Virology. 62: 4499-4509. PMID 3263510 DOI: 10.1128/Jvi.62.12.4499-4509.1988  0.634
1988 Khalili K, Brady J, Pipas JM, Spence SL, Sadofsky M, Khoury G. Carboxyl-terminal mutants of the large tumor antigen of simian virus 40: a role for the early protein late in the lytic cycle Proceedings of the National Academy of Sciences of the United States of America. 85: 354-358. PMID 2829182 DOI: 10.1073/Pnas.85.2.354  0.631
1987 Green J, Brady J, Khoury G. 72-bp element contains a critical control region for SV40 late expression in Xenopus laevis oocytes Virology. 159: 339-349. PMID 3039731 DOI: 10.1016/0042-6822(87)90472-7  0.629
1987 Brady J, Jeang KT, Duvall J, Khoury G. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. Journal of Virology. 61: 2175-2181. PMID 3035218 DOI: 10.1128/Jvi.61.7.2175-2181.1987  0.626
1987 Khalili K, Brady J, Khoury G. Translational regulation of SV40 early mRNA defines a new viral protein Cell. 48: 639-645. PMID 3028644 DOI: 10.1016/0092-8674(87)90242-X  0.663
1986 Loeken MR, Khoury G, Brady J. Stimulation of the adenovirus E2 promoter by simian virus 40 T antigen or E1A occurs by different mechanisms. Molecular and Cellular Biology. 6: 2020-6. PMID 3023915 DOI: 10.1128/Mcb.6.6.2020  0.614
1986 Khalili K, Khoury G, Brady J. Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression Journal of Virology. 60: 935-942. PMID 3023682 DOI: 10.1128/Jvi.60.3.935-942.1986  0.664
1984 Brady J, Radonovich M, Thoren M, Das G, Salzman NP. Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription. Molecular and Cellular Biology. 4: 133-41. PMID 6321950 DOI: 10.1128/Mcb.4.1.133  0.478
1981 Brady J, Radonovich M, Lavialle C, Salzman NP. Simian virus 40 maturation: chromatin modifications increase the accessibility of viral DNA to nuclease and RNA polymerase. Journal of Virology. 39: 603-11. PMID 6268846 DOI: 10.1128/Jvi.39.2.603-611.1981  0.34
Show low-probability matches.